How conquering a rare leukemia in children revolutionized cancer care for millions
- OPACC
- Jun 11, 2019
- 1 min read
"That success story — one with deep Philadelphia roots — is even more phenomenal than it sounds. While ALL accounts for almost a third of pediatric cancers, it is a rare cancer overall, with about 2,900 annual diagnoses in the United States. Yet this uncommon malignancy is the tie that binds giants of oncology research, scientific breakthroughs, revolutionary drugs, and startling philanthropy, not to mention a Pulitzer Prize-winning book that became an acclaimed PBS documentary series."
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...